Journal article
Progression of Liver Fibrosis and Modern Combination Antiretroviral Therapy Regimens in HIV-Hepatitis C–Coinfected Persons
Abstract
BACKGROUND: Liver diseases progress faster in human immunodeficiency virus (HIV)-hepatitis C virus (HCV)-coinfected persons than HIV-monoinfected persons. The aim of this study was to compare rates of liver fibrosis progression (measured by the aspartate-to-platelet ratio index [APRI]) among HIV-HCV-coinfected users of modern protease inhibitor (PI)- and nonnucleoside reverse transcriptase inhibitor (NNRTI)-based regimens with a backbone of …
Authors
Brunet L; Moodie EEM; Young J; Cox J; Hull M; Cooper C; Walmsley S; Martel-Laferrière V; Rachlis A; Klein MB
Journal
Clinical Infectious Diseases, Vol. 62, No. 2, pp. 242–249
Publisher
Oxford University Press (OUP)
Publication Date
January 15, 2016
DOI
10.1093/cid/civ838
ISSN
1058-4838